Leukotriene antagonists for oral squamous cell carcinoma

Details Leukotriene antagonists for oral squamous cell carcinoma Leukotriene antagonists for oral squamous cell carcinoma

A - Human Necessities

61

K

A61K 31/495 (2006.01) A61K 31/19 (2006.01) A61K 31/192 (2006.01) A61K 31/194 (2006.01) A61K 31/275 (2006.01) A61K 31/343 (2006.01) A61K 31/352 (2006.01) A61K 31/41 (2006.01) A61K 31/44 (2006.01) A61K 31/445 (2006.01) A61K 31/50 (2006.01) A61K 31/535 (2006.01)

Patent

CA 2274855

This invention provides methods for the treatment or inhibition of oral squamous cell carcinoma which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene B4 antagonist.

L'invention concerne des procédés destinés à traiter ou à prévenir l'épithélioma spino-cellulaire oral. Ces procédés impliquent d'administrer une dose efficace d'un composé présentant une activité d'antagoniste de leukotriène B4 à un sujet mammifère qui nécessite un tel traitement.

Affiliated with

Also associated with

Rating

Leukotriene antagonists for oral squamous cell carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Leukotriene antagonists for oral squamous cell carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene antagonists for oral squamous cell carcinoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1751175